| |
 |
|
Class Information
Number: 514/8
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > Glycoprotein (carbohydrate containing)
Description: Subject matter which contains a carbohydrate or derivative thereof attached to the peptide.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6777387 |
Terminally-branched polymeric linkers containing extension moieties and polymeric conjugates containing the same |
Aug. 17, 2004 |
| 6770272 |
Treatment of diabetes |
Aug. 3, 2004 |
| 6770621 |
Polyacid glycopeptide derivatives |
Aug. 3, 2004 |
| 6770622 |
N-terminally truncated galectin-3 for use in treating cancer |
Aug. 3, 2004 |
| 6767891 |
Peptides with wound healing activity |
Jul. 27, 2004 |
| 6764681 |
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
Jul. 20, 2004 |
| 6759386 |
Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease |
Jul. 6, 2004 |
| 6759388 |
Surfactants that mimic the glycocalyx |
Jul. 6, 2004 |
| 6756361 |
Enterococcus antigens and vaccines |
Jun. 29, 2004 |
| 6747002 |
Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
Jun. 8, 2004 |
| 6747003 |
Modified vitamin K-dependent polypeptides |
Jun. 8, 2004 |
| 6743422 |
Keratinocyte growth factor-2 products |
Jun. 1, 2004 |
| 6743774 |
Tribonectins |
Jun. 1, 2004 |
| 6743775 |
Slow release formulations comprising anionic polysaccharide |
Jun. 1, 2004 |
| 6740635 |
Antiviral linear polymers |
May. 25, 2004 |
| 6737064 |
Method for the diagnosis of neoplastic tissue comprising administering a vasopermeability enhancing peptide of human interleukin-2 |
May. 18, 2004 |
| 6737402 |
Method of preparing fetuin to induce apoptosis |
May. 18, 2004 |
| 6734160 |
Methods of treating diabetes mellitus with OB polypeptides |
May. 11, 2004 |
| 6734165 |
Method for re-sensitizing vancomycin resistant bacteria which selectively cleave a cell wall depsipeptide |
May. 11, 2004 |
| 6723319 |
Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodies |
Apr. 20, 2004 |
| 6720311 |
Polypeptide for the treatment of cancer and a method for preparation thereof |
Apr. 13, 2004 |
| 6716815 |
Nutritional intervention composition for enhancing and extending satiety |
Apr. 6, 2004 |
| 6713052 |
Method of mobilizing stem cells with chemokine .beta.-8 |
Mar. 30, 2004 |
| 6713280 |
Enhancement of peptide cellular uptake |
Mar. 30, 2004 |
| 6713448 |
Substantially pure glycopeptide antibiotics AC-98-1; AC-98-2; AC-98-3; AC-98-4 and AC-98-5 |
Mar. 30, 2004 |
| 6709649 |
RANTES derived peptides with anti-HIV activity |
Mar. 23, 2004 |
| 6709658 |
Pneumococcal vaccines formulated with interleukin-12 |
Mar. 23, 2004 |
| 6710029 |
Dehydrodidemnin B |
Mar. 23, 2004 |
| 6706261 |
Compositions and methods comprising immunogenic muteins of interleukin-6 |
Mar. 16, 2004 |
| 6706681 |
HCG liquid formulations |
Mar. 16, 2004 |
| 6699688 |
Human platelet F11 receptor |
Mar. 2, 2004 |
| 6699836 |
Vancomycin analogs |
Mar. 2, 2004 |
| 6696056 |
Pharmaceutical compositions of erythropoietin |
Feb. 24, 2004 |
| 6696480 |
Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization |
Feb. 24, 2004 |
| 6692920 |
Antibodies to a chemokine expressed in inflamed adenoid |
Feb. 17, 2004 |
| 6692931 |
Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof |
Feb. 17, 2004 |
| 6693074 |
Cystine depleted glycoprotein hormones |
Feb. 17, 2004 |
| 6693075 |
Modified vitamin K-dependent polypeptides |
Feb. 17, 2004 |
| 6689351 |
Use of GM-CSF to promote accelerated wound healing |
Feb. 10, 2004 |
| 6689353 |
Stabilized interleukin 2 |
Feb. 10, 2004 |
| 6689748 |
Method of treating mast cell activation-induced diseases with a proteoglycan |
Feb. 10, 2004 |
| 6685931 |
Treatment of hepatitis C virus infections with interleukin-10 |
Feb. 3, 2004 |
| 6685932 |
Coiled-coil dimer derived antagonists of 4-helix bundle cytokines, design and uses thereof |
Feb. 3, 2004 |
| 6685941 |
Methods of treating autoimmune disease via CTLA-4Ig |
Feb. 3, 2004 |
| 6682739 |
Methods of inhibiting osteoclastogenesis |
Jan. 27, 2004 |
| 6683050 |
Compounds with anti-KS and anti-HIV activity |
Jan. 27, 2004 |
| 6680291 |
Modified ciliary neurotrophic factor, method of making and methods of use thereof |
Jan. 20, 2004 |
| 6676985 |
Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
Jan. 13, 2004 |
| 6669941 |
Soluble lymphotoxin-.beta. receptor as a therapeutic agent for treating TH-1 cell-associated autoimmune disease |
Dec. 30, 2003 |
| 6670325 |
Treatment of osteocarcinoma with alpha-1--antitrypsin or secretory leucocyte protease inhibitor |
Dec. 30, 2003 |
|
|
|
